Ep. 394 - Security concerns in U.S., China reshaping biotech
BioCentury This Week

Ep. 394 - Security concerns in U.S., China reshaping biotech

Oct 27, 2026
33:40
S7 · E394
-(0)

About this episode

Proposed U.S. Treasury rules implementing the COINS Act would bar U.S. equity investments, joint ventures and co-development deals with China biotechs, potentially ensnaring Asia-to-West NewCos while leaving licensing intact. On the latest BioCentury This Week podcast, BioCentury’s analysts assess the rule’s implications for cross-border dealmaking, the competitive opening it may create for European companies, and China’s narrower-than-feared draft export controls on platform technologies. Th...

Comments

Rate this episode

Episode Details

Author
BioCentury
Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy